Elderly Health Month: Spotlight on Alzheimer’s, Dementia, and the Power of Memory Care Advocacy
As we honor Elderly Health Month this December, it’s a timely moment to reflect on the unique health challenges facing older adults—particularly those navigating Alzheimer’s disease and other forms of dementia. These conditions not only affect memory and cognition but also deeply impact families, caregivers, and the broader healthcare system. Fortunately, new therapies and compassionate care models are reshaping what support can look like.
Alzheimer’s & Dementia: A Growing Concern
Alzheimer’s disease is the most common form of dementia, affecting over 6 million Americans. It’s a progressive neurological disorder that gradually impairs memory, reasoning, and daily functioning. While there is no cure, recent advances in treatment offer new hope—especially when paired with thoughtful, patient-centered care.
Leqembi and Kisunla: New Frontiers in Alzheimer’s Treatment
Sage Infusion is proud to offer two groundbreaking therapies for early-stage Alzheimer’s: Leqembi (lecanemab)and Kisunla (donanemab). These anti-amyloid monoclonal antibodies target the buildup of amyloid plaques in the brain—a hallmark of Alzheimer’s pathology.
- Leqembi was the first FDA-approved therapy shown to slow cognitive decline in early Alzheimer’s by reducing amyloid burden.
- Kisunla, a newer entrant, offers a similar mechanism with a potentially shorter treatment duration, depending on patient response.
Both medications require a series of MRIs to monitor safety and progression, and they come with important considerations around side effects, including infusion reactions and amyloid-related imaging abnormalities (ARIA).
Memory Care Advocacy
Understanding that Alzheimer’s care goes beyond medication, Sage Infusion has developed a Memory Care Advocacy Program—a specialized initiative designed to guide patients and families through every step of the infusion journey.
Here’s what the program offers:
- Trained Memory Care Specialists who talk with patients to explain what to expect from Leqembi or Kisunla, including timelines, monitoring, and potential side effects.
- MRI Coordination Support, helping patients navigate the imaging series required for treatment safety and eligibility.
- Provider Communication Bridge, ensuring seamless coordination between ordering physicians and the infusion team so patients feel informed, supported, and never left wondering who to ask.
- Side Effect Education, with compassionate guidance on what symptoms to watch for and how to respond.
This program is especially valuable for patients who may feel overwhelmed by the complexity of Alzheimer’s treatment or unsure about how to advocate for themselves.
A Holistic Approach to Elderly Health
Elderly Health Month reminds us that aging well requires more than clinical interventions—it demands empathy, education, and systems that prioritize dignity. Sage Infusion’s commitment to Alzheimer’s care reflects this ethos, offering not just cutting-edge therapies but also the human connection that makes healing possible.
Whether you’re a caregiver, a patient, or a provider, Sage Infusion invites you to learn more about its Memory Care Advocacy Program and how Leqembi and Kisunla may fit into a broader plan for cognitive health.